Genetic mutations could help guide use of pancreatic cancer drugs; New insights on neuropathic pain, esophageal cancer;

> Johns Hopkins Kimmel Cancer Center scientists say they found at least one-third of the patients' pancreatic cancer tumors have genetic mutations that may someday help guide precision therapy of their disease. Release

> A research group at Hiroshima University has demonstrated that the downregulation of spinal astrocyte connexin43 (Cx43) expression causes sustained neuropathic pain following peripheral nerve injury. Release

> U.K. scientists have found that "jumping genes" may add to the genetic chaos behind more than three-quarters of esophageal cancer cases. Release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.